A comparative, randomised, double-blind study of trazodone prolonged-release and paroxetine in the treatment of patients with major depressive disorder

By Kasper S.   Olivieri L.   Di Loreto G.   Dionisio P.  

Current Medical Research and Opinion, Vol. 21, Iss. 8, 2005-08 ,pp. : 1139-1146

Informa Healthcare

Access to resources Recommend Favorite

Escitalopram versus sertraline in the treatment of major depressive disorder: a randomized clinical trial

By Ventura Daniel   Armstrong Edward P.   Skrepnek Grant H.   Haim Erder M.  

Current Medical Research and Opinion, Vol. 23, Iss. 2, 2007-02 ,pp. : 245-250

Informa Healthcare

Access to resources Recommend Favorite

A randomized, double-blind, 24-week study of escitalopram (10 mg/day) versus citalopram (20 mg/day) in primary care patients with major depressive disorder

By Colonna Lucien   Andersen Henning Friis   Reines Elin Heldbo  

Current Medical Research and Opinion, Vol. 21, Iss. 10, 2005-10 ,pp. : 1659-1668

Informa Healthcare

Access to resources Recommend Favorite

A randomized, double-blind trial of 2.5 mg and 5 mg vortioxetine (Lu AA21004) versus placebo for 8 weeks in adults with major depressive disorder

By Mahableshwarkar Atul R.   Jacobsen Paula L.   Chen Yinzhong  

Current Medical Research and Opinion, Vol. 29, Iss. 3, 2013-03 ,pp. : 217-226

Informa Healthcare

Access to resources Recommend Favorite

Ropinirole 24-hour prolonged release and ropinirole immediate release in early Parkinson's disease: a randomized, double-blind, non-inferiority crossover study

By Stocchi Fabrizio   Hersh Bonnie P.   Scott Burton L.   Nausieda Paul A.   Giorgi Luigi    

Current Medical Research and Opinion, Vol. 24, Iss. 10, 2008-10 ,pp. : 2883-2895

Informa Healthcare

Access to resources Recommend Favorite